BCYC vs BLK · rev $1.5M vs P/E 27, rev $24.22B
Bicycle Therapeutics Ltd (BCYC) versus BlackRock Inc (BLK) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
BCYC currently screens at market cap $554.0M. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Not investment advice. Open the BCYC and BLK stock pages for the full models.
Not investment advice.